why choose us

First received: September 26, 2024

Clinical Trial: Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autism Spectrum Disorder

Study Type: INTERVENTIONAL


Official Title: Application of Ketamine Combined With Dexmedetomidine Sedation in Magnetic Resonance Imaging of Children With Autism and Autism Spectrum Disorder:a-Randomized Controlled Trial

Brief Summary: Objective: To investigate the use of ketamine combined with dexmedetomidine for sedation in children with autism spectrum disorder, Methods:aged 2-6 years,, ASA grade I or II.The children were randomly divided into three groups using a random number table method: a low-dose dexmedetomidine group (DEXL group,n=100?The high-dose group of dexmedetomidine (DEXH group,n=100) and the group of esketamine combined with dexmedetomidine (DEXE group,n=100).The DEXL group received 2.5 ? g/kg of dexmedetomidine nasal…

Read more